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BCL-2 familyThe assembling of distinct signaling protein complexes at the endoplasmic reticulum (ER)membrane controls
several stress responses related to calcium homeostasis, autophagy, ER morphogenesis and protein folding.
Diverse pathological conditions interfere with the function of the ER altering protein folding, a condition
known as “ER stress”. Adaptation to ER stress depends on the activation of the unfolded protein response
(UPR) and protein degradation pathways such as autophagy. Under chronic or irreversible ER stress, cells
undergo apoptosis, where the BCL-2 protein family plays a crucial role at the mitochondria to trigger
cytochrome c release and apoptosome assembly. Several BCL2 family members also regulate physiological
processes at the ER through dynamic interactomes. Here we provide a comprehensive view of the roles of the
BCL-2 family of proteins in mediating the molecular crosstalk between the ER and mitochondria to initiate
apoptosis, in addition to their emerging functions in adaptation to stress, including autophagy, UPR, calcium
homeostasis and organelle morphogenesis. We envision a model where BCL-2-containing complexes may
operate as stress rheostats that, beyond their known apoptosis functions at the mitochondria, determine the
amplitude and kinetics of adaptive responses against ER-related injuries. This article is part of a Special Issue
entitled Mitochondria: the deadly organelle.lded protein response; IRE1α,
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Regulated cell death is a crucial event for development and cell
physiology, and alteration of this process could result in the occurrence
of severe human diseases such as inﬂammation, cancer, neoplasia,
neurodegeneration or autoimmune disorders [1–5]. Subcellular or-
ganelle stress is observed in many pathological processes, where
complex signaling responsesmediate the adaptation to stress or trigger
apoptosis when a critical threshold of damage is reached [6]. Executionof apoptosis depends in part on the activation of caspases, a process
tightly regulated by the BCL-2 family of proteins at the mitochondria.
Here, we summarize and highlight some relevant aspects of the
crosstalk between the ER and mitochondria in the regulation of
apoptosis. We also discuss how components of this pathwaymodulate
signaling pathways through assembling protein complexes containing
components of the BCL-2 protein family and stress regulators. Data
discussed here suggest that several BCL-2 protein family members
have novel functions beyond apoptosis in regulating ER calcium
homeostasis and specialized stress responses such as autophagy and
the unfolded protein response (UPR).
2. Regulation of apoptosis by the BCL-2 protein family
The BCL-2 family of proteins is essential for the regulation of
intrinsic cell death, by controlling the release of cytochrome c and
apoptosome assembling. The BCL-2 family of proteins is comprised by
both pro- and anti-apoptotic members deﬁned by different domains
and classiﬁed by the sequence homology in up to four α-helical
domains called BCL-2 homology BH1 to BH4 [7] (Fig. 1A). The family is
subdivided into pro-apoptotic members that contain BH1 to BH3
domains (i.e. BAX and BAK). The second subset is termed “BH3-only”
members (i.e. BID, BIK, BIM, PUMA and NOXA) (Fig. 1A), which
contain a single α-helical domain critical for activation of apoptosis
Fig. 1. The BCL-2 family of proteins. (a) The BCL-2 family of proteins is deﬁned by the presence of up to four domains homologous to BCL-2. This group of proteins is functionally
subdivided into pro- and anti-apoptotic proteins. Pro-apoptotic members can be further subdivided into more fully conserved “multidomain”members possessing BCL-2 homology
domains 1, 2, and 3, or “BH3-only”members which display only about nine amino acids of sequence homology within the single death-promoting domain. (b) Left panel: One model
of activation of BAX/BAK by BH3-only proteins. Some BH3-only proteins activate BAX/BAK through a direct binding (i.e. tBID, BIM, and PUMA, activator BH3-only proteins). They also
bind anti-apoptotic proteins (BCL-2, BCL-XL, and MCL-1), which inhibit their pro-apoptotic activity. Other BH3-only proteins, termed de-repressors or sensitizers, antagonize and
inhibit speciﬁc subsets of pro-survival BCL-2 proteins (BAD inhibits BCL-2 and BCL-XL, and NOXA inhibits MCL-1), lowering the threshold for activation of apoptosis by releasing
activator BH3-only proteins bound to anti-apoptotic proteins. Right panel: Alternatively, another model proposes that differential binding of BH3-only proteins to anti-apoptotic
BCL-2 family members may neutralize their anti-apoptotic activity, releasing or activating an unknown factor (here termed as X) that leads to BAX and BAK oligomerization at the
mitochondria, and cytochrome c release.
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the BH3-domain [10–12]. A second group of family members contains
BH1, BH2, BH3, and BH4 domains, and is composed of several
apoptosis-inhibitory proteins (i.e. BCL-2, BCL-XL, MCL-1, BCL-w, BCL-
2A1, BCL-B and many others) [8,13]. Several anti- and pro-apoptotic
components of the BCL-2 protein family share similar three-
dimensional structures, and a complex hierarchy of biochemical
interactions operates to regulate apoptosis [9,14]. Genetic and
biochemical studies indicate that BAX and BAK function in concert
as a major core of the intrinsic apoptosis pathway in the mitochondria
[15,16]. Upstream BH3-only proteins respond to particular apoptotic
signals and subsequently trigger the conformational activation of BAX
and BAK, inducing their intramembranous homo-oligomerization and
resultant mitochondrial outer membrane permeabilization (MOMP)
[17]. MOMP is a key step for the release of cytochrome c and the
assembling of the apoptosome [9,17]. The BH3-only proteins can be
functionally separated into two subtypes: (i) activators (i.e. tBID, BIM,and PUMA) that directly engage BAX and BAK to trigger cytochrome c
release, but are sequestered by anti-apoptotic BCL-2 molecules; and
(ii) sensitizers or inactivators (i.e. BAD and NOXA) that only bind to
and antagonize anti-apoptotic BCL-2 members releasing activator
BH3-only proteins [18–20] (Fig. 1B). Alternatively, differential
binding to anti-apoptotic proteins may explain the action of activator
and sensitizer/inactivator BH3-only proteins [21] (Fig. 1B), or a
combination of both models [22].
Different BCL-2 family members have distinct patterns of devel-
opmental expression, subcellular localization, and differential respon-
siveness depending on the speciﬁc death stimuli (reviewed in [8,23]).
For example, speciﬁc BH3-only proteins or combinations of them
operate as sentinels of cellular damage in response to various death
stimuli (i.e. oxidative stress, growth factor deprivation, DNA damage,
death receptor engagement, ER stress, etc.) [8], and they can be
activated either by transcriptional upregulation or through post-
translational modiﬁcations [24].
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3.1. The unfolded protein response
The ER has multiple complex functions, highlighting its major role
in calcium storage and protein synthesis/folding. Other important
functions include biosynthesis of steroids, cholesterol, and other
lipids. Membrane-spanning and secreted proteins are synthesized in
the ER and undergo post-translational modiﬁcations, folding, quality
control and oligomerization. A physiological demand of high secretory
activity, or pathologic conditions including proteasome inhibition,
mutant protein expression, ER calcium depletion, or redox changes,
interferes with oxidative protein folding at the ER lumen, resulting in
the accumulation of unfolded or misfolded intermediates, a cellular
condition referred to as “ER stress” [25,26].
To alleviate ER stress cells activate a signaling pathway known as
the UPR. The UPR transmits information about the protein folding
status in the ER lumen to the cytoplasm and nucleus to decrease the
unfolded protein load [27]. However, if the UPR's mechanisms of
adaptation and cell survival are insufﬁcient to decrease the unfolded
protein load, the UPR initiates cell death by apoptosis [28,29].
Therefore, the capacity to handle ER stress constitutes an important
step in maintaining the balance between the life and death of a cell.
UPR signaling is initiated by at least three distinct transmembrane
stress sensors: IRE1α (Inositol-Requiring transmembrane kinase/
Endonuclease), PERK (PKR-like ER Kinase), and ATF6 (Activating
Transcription Factor 6). IRE1α is a Ser/Thr protein kinase and
endoribonuclease that, upon activation, initiates the unconventional
splicing of the mRNA encoding the transcriptional factor X-Box-
binding protein 1 (XBP-1) [30–32]. In mammalian cells, a 26
nucleotide intron of xbp-1 mRNA is spliced out by activated IRE1α,
leading to a shift in the coding reading frame. This splicing event
promotes the expression of a more stable and potent transcriptional
activator called XBP-1s that controls the upregulation of UPR-related
genes involved in protein folding, redox metabolism, ER-associated
degradation and protein quality control [33]. Indeed, XBP-1 expres-Fig. 2. Regulation of the UPRosome signaling platform by the BCL-2 protein family. Inactive
cytosolic domain binds to BI-1, and JIK. Under ER stress conditions, accumulation of misfolde
of BIP over IRE1α. The putative interaction between the ER luminal domain of IRE1αwith un
autophosphorylation and the activation of the endoribonuclease domain. The UPRosome int
IRE1α activity, which may include PTP-1B, AIP1, HSP72, RACK1, BAX/BAK and presumably B
and TRAF2, initiating the activation of ASK1/JIK and the subsequent activity of alarm stress si
TRAF2 promotes NF-κB activation. Also, IRE1αmay regulate the processing of murine pro-c
Box-binding protein-1 (XBP-1s), with the result of an active transcription factor termed X
mRNAs (mRNA decay). IRE1α can recover the inactive state by interacting with BI-1 and thsion is essential for the proper function of specialized secretory organs
such as liver, pancreas, and salivary gland, as well as B-lymphocytes
[34]. In addition, recent reports indicate that the RNAse activity of
IRE1α mediates the rapid degradation of a subset of mRNAs, that
either encode ER proteins with transmembrane domains or secreted
proteins that may be difﬁcult to fold [33,35,36], contributing to
alleviation of ER stress.
Activated PERK phosphorylates the eukaryotic translation initia-
tion factor 2α (eIF2α), inhibiting its activity [26]. eIF2α phosphory-
lation augments the speciﬁc translation of the mRNA encoding
Activation of Transcription-4 (ATF4), a transcription factor essential
for the upregulation of many UPR-associated genes that function in
amino acid metabolism, redox homeostasis, autophagy, and apoptosis
[26]. Finally, activation of ATF6 leads to its translocation from the ER
membrane to the Golgi where it is proteolytically processed, releasing
the cytosolic domain which translocates to the nucleus acting as a
transcription factor that upregulates several ER chaperones and
ERAD-related genes [26].
IRE1α activation also controls the activation of stress responses
involving JNK (Jun N-terminal Kinase) [37,38], ERK (Extracellular
signal-regulated kinase) [39], p38MAPK [40], NF-κB (Nuclear Factor
kappa-light-chain-enhancer of activated B cells) [41] and possibly the
ER-resident caspase-12 in rodent cells [42]. Additionally, c-Jun N-
terminal inhibitory kinase (JIK) was identiﬁed as a binding partner
and modulator of the IRE1α/TRAF2 complex [42] (Fig. 2).
3.2. Crosstalk between the BCL-2 family of proteins and the UPR: a bi-
functional role
The most conserved ER stress sensor is IRE1α. Different reports
indicate that IRE1α activity is regulated by speciﬁc interactions with
different pro- and anti-apoptotic proteins through a scaffold referred
to as the UPRosome [34]. As part of this platform, we initially described
a new function of BAX and BAKwhere theymodulate the amplitude of
IRE1α signaling at the ER membrane [43]. This regulation is mediated
by a physical association between the cytosolic domains of IRE1αwithIRE1α (monomer) binds in the luminal domain to the ER chaperone BIP and through
d protein on the ER promotes IRE1α activation and releasing its partial inhibitory effect
folded proteins may also help in stabilizing its oligomeric and active state, leading to its
eractome is composed of several proteins that modulate the amplitude and kinetics of
H3-only proteins and other components. The active form of IRE1α interacts with AIP1
gnals mediated by JNK, p38MAPK and ERK pathway. The sequestration of IKK by IRE1α/
aspase-12, through the binding of TRAF2. In addition, IRE1α processes the mRNA of X-
BP-1s. The RNAse activity of IRE1α also mediates the rapid degradation of a subset of
e chaperone BIP.
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(DKO) cells display a speciﬁc deﬁciency in the autophosphorylation
and oligomerization of IRE1α, leading to a stable association with BiP.
Similarly, BAX/BAK deﬁcient mice and cells show a decreased
expression of IRE1α-downstream signals including JNK phosphory-
lation and XBP-1s expression under experimental ER stress condi-
tions [43]. At the biochemical level, BAX and BAK form a protein
complex with the cytosolic domain of IRE1α, possibly stabilizing its
active form. The BH1 and BH3 domains were shown to be necessary
for this regulatory activity [43].
Overall, these ﬁndings suggest a new role for pro-apoptotic family
members to act as accessory factors for the instigation of certain UPR
signaling events. In this line, during early steps of UPR response a
subpopulation of BAX and BAK may instigate pro-survival effects in
adaptation to ER stress through IRE1α signaling, or engage mito-
chondrial-mediated apoptosis when homeostasis cannot be restored
(bi-functional roles).
Under prolonged ER stress IRE1α activity is turned off, suggesting
the existence of components that negatively control its activity.
Whereas PERKmaintains its signaling, possibly sensitizing chronically
damaged cells to apoptosis [32,44,45]. Accordingly, we and others
recently reported that the ER located anti-apoptotic protein Trans-
membrane BAX Inhibitor Motif Containing (TMBIM)-6, also known as
BAX inhibitor-1 (BI-1), regulates IRE1α activity [46–48], and it is
required for the inactivation of IRE1α [49], possibly due to a concerted
mechanism that requires a direct binding and displacement of BAX/
BAK from the UPRosome [48,49] (Fig. 2). BI-1 is an ER-located protein
that is predicted to have anti-apoptotic activities, contained within
the TMBIM family of evolutionary conserved proteins [50–52].
Although BI-1 was identiﬁed on a yeast screening as a gene that
blocks BAX-mediated toxicity, immunoprecipitation experiments
failed to detect a physical interaction with BAX [53]. Interestingly,
BI-1 physically interacts with BCL-2 and BCL-XL [49,53]. However, it is
not knownwhat the functional impact of protein–protein interactions
between BI-1 and BCL-2 family members are. It may be feasible that
they form heterodimeric complexes that synergize in the inhibition of
apoptosis.
Whether or not other BCL-2 family members modulate the IRE1α
UPRosome remains unexplored. Interestingly, the speciﬁc expression
of the BH3-only proteins BIM and PUMA at the ER membrane leads to
the activation of IRE1α/JNK pathway on a BAK-dependent manner
[54]. These ﬁndings were obtained in the absence of any ER stressor
when the proteins are overexpressed and targeted to the ER,
indirectly suggesting that these BH3-only proteins are potent
activators of the IRE1α UPR branch. In this particular cell system,
engagement of IRE1α/JNK was proposed to have a pro-apoptotic
effect through an unknown signaling to the mitochondria [55]. It was
explored whether or not this phenotype was related to a physical
interaction between BIM/PUMA and IRE1α. The authors proposed a
model where alterations of calcium homeostasis are an upstream
component involved in the activation of JNK by BH3-only proteins.
IRE1α is also controlled by the expression of the ER-located
protein tyrosine phosphatase 1B (PTP-1B) [40]. Similarly, the pro-
apoptotic protein ASK1-interacting protein 1 (AIP1) speciﬁcally
regulates and enhances IRE1α signaling under cellular ER stress,
possibly through the formation of a protein complex [56]. Recently,
HSP72 and RACK1 proteins were identiﬁed as new interacting
proteins that instigate IRE1α activity [57,58] (Fig. 2). Interestingly,
BAX, BAK, BI-1, AIP1, PTP-1B and HSP72 expression speciﬁcally affects
IRE1α activation and not PERK-dependent signaling [40,43,49,58],
and all of them have been linked to the regulation of apoptosis
suggesting bi-functional roles [59].
TRAF2 interacts with pro-caspase-12 and promotes its clustering
and activation in response to ER stress [42], which may be linked to
IRE1α and apoptosis [37,42]. Since the IRE1α/TRAF2/ASK1 complex
activates JNK signaling [37,38], it may also induce apoptotic cell deathin an analogous fashion to what has been described for the TNF
receptor [19,37,38,41,60,61], but the mechanism linking these two
phenomena is not clear. In contrast to these models, IRE1α/XBP-1
signaling is traditionally linked to adaptation to ER stress and cell
survival (reviewed in [27,62]).
3.3. BH3-only proteins and ER-stress-mediated apoptosis
Several reports in the literature addressed the possible role of BH3-
only proteins in the modulation of apoptotic cell death under chronic
or irreversible ER stress conditions and the molecular crosstalk with
the mitochondria to trigger cytochrome c release [28,63]. Although
the possible mechanisms related to the induction of apoptosis by ER
stress are not fully understood, many relevant regulators have been
identiﬁed in the last decade where BH3-only proteins have a crucial
role in triggering BAX and BAK activation in the mitochondria
(reviewed in [64–66]). Some BH3-only proteins that undergo
transcriptional upregulation under ER stress include PUMA and
NOXA [67]. These proteins are mostly known as genes upregulated
by DNA damage, but under prolonged ER stress they are transcrip-
tionally induced on a p53-dependent manner [68,69] (Fig. 3).
However, it is not clear what the signaling events regulating p53 by
ER stress are. Interestingly, a recent report suggested that CHOP may
also regulate PUMA expression [70]. Another study revealed that
NOXA can be induced on an ATF4-dependent manner, independent of
CHOP or IRE1α expression [71]. An early cDNA microarray analysis
showed that PUMA is upregulated by ER stress [67] and a global RNA
interference screen for genes that regulate ER stress-mediated
apoptosis corroborated the functional role of PUMA in this process
[72], and identiﬁed NOXA as an additional apoptosis mediator.
Additionally, MEFs cells lacking puma or noxa genes are partially
resistant to ER stress-mediated apoptosis [69]. PUMA and NOXA are
also upregulated under ER stress conditions in a melanoma cell
context in addition to MCL-1 [73]. Anticancer agents that induce ER
stress such as Eeyarestatin I, a potent inhibitor of protein translocation
and inhibitor of ERAD, leads to NOXA upregulation by the ATF3 and
ATF4 transcriptional factors [74].
Another BH3-onlymember, BIK, is primarily localized to the ER but
it is neither transcriptionally nor post-translationally induced by ER
stress [75]. BIK controls the release of calcium by BAK oligomerization
at the ER triggering apoptosis (see below) [76]. Furthermore, BIM is
transcriptionally and post-translationally upregulated by ER stress
[67,77]. BIM mRNA levels are upregulated by the transcription factor
CHOP [77]. In addition, BCL-2 is downregulated by CHOP [77] (Fig. 3).
Moreover, BIM deﬁcient mice are resistant to ER stress-induced
apoptosis in vivo, similar to the phenotype described for cells andmice
deﬁcient in CHOP expression [78–80] and BAX and BAK conditional
DKO mice [43]. BIM is also upregulated by post-translational
mechanisms [24,81]. Under normal conditions, BIM is found in the
dynein motor complex of the microtubule cytoskeleton. However,
under ER stress BIM translocates to the ER where it may promote
caspase activation through an unknown mechanism [82]. Dephos-
phorylation of BIM by the serine/threonine phosphatase 2A (PP2A)
also increases its pro-apoptotic activity under ER stress condition in
different cell types, preventing its ubiquitination and proteasomal
degradation [77]. Correlative studies in rat primary cultures showed
that BAD is also activated by dephosphorylation and produce
apoptosis in cortical neurons undergoing ER stress [83]. Another
BH3-only protein, BID, is post-translationally upregulated by caspase-
2-dependent proteolytic activation upon ER stress, leading to BAX/
BAK activation at the mitochondria [84], however a deﬁned
mechanism linking the UPR and caspase-2 is still lacking.
In addition to the mitochondria, BAX and BAK oligomerize at the
ER membrane under ER stress conditions [85], a phenomena
instigated by BH3-only proteins [15]. Interestingly, a new report
suggest that activation of BAX and BAK proteins increases ER
Fig. 3. Role of the BCL-2 protein family in the apoptotic crosstalk between ER and mitochondria during chronic ER stress. (a) The UPR stress sensors promote the transcriptional
activity of ATF4, p53 and CHOP. PUMA and NOXA are transcriptionally induced in cells undergoing ER stress in a p53-dependent manner. BIM is also upregulated and BCL-2 is
downregulated by the transcription factor CHOP. (b) BCL-2 family members also regulate ER calcium homeostasis at the ER. ER calcium release followed by mitochondrial calcium
uptake may inﬂuence cytochrome c release by controlling the permeability transition pore (PTP). (c) BIM protein levels can be regulated by phosphorylation, ubiquitination and
proteasomal degradation. BIM is desphosphorylated by PP2A increasing its pro-apoptotic activity. Under physiological conditions, BIM is found in the dynein motor complex of the
microtubule cytoskeleton and could also associate with BCL-2 in the ER membrane. (d) The activation of BH3-only proteins BIM, PUMA and NOXA leads to homo-oligomerization of
BAX and/or BAK at the mitochondria with the subsequent release of cytochrome c and caspase-dependent apoptosis. (e) BAD may also trigger apoptosis by its dephosphorylation
under ER stress, and under the same conditions BID activates apoptosis when it is cleaved by caspase-2.
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during ER stress-induced apoptosis [86]. ER permeability may
represent a new component regulating the activation of cell death.
This novel observation may open the possibility of identifying new
pathways in the regulation of ER stress-mediated apoptosis in an
analogous fashion as the apoptosome. Interestingly, we described that
BAX-channel inhibitors block apoptosis under different cell death
settings, suggesting a direct role of the BAX forming pore activity on
cell death [87]. It will be also interesting to explore if BAX/BAK pores
at the ER directly control calcium release from the ER. The use of BAX-
channel inhibitors may help address this hypothesis.
4. Relationship between the BCL-2 protein family and ER calcium
homeostasis.
A large amount of evidence indicates that the expression balance
between anti- and pro-apoptotic proteins at the ER membrane
determines the steady state ER-calcium content, possibly by modu-
lating a passive calcium leak (reviewed in [88–90]). This calcium-
regulating activity by BCL-2-related proteins has a direct impact on
the amount of calcium released after agonist stimulation (Fig. 3). Forexample, BAX and BAK DKO cells have decreased ER calcium content
and stimulated release [85,91], similar to the phenotype of BCL-2
overexpressing cells (see examples in [92–98]). Different BH3-only
proteins are located at the ER or translocate to its membrane under
stress conditions and impact calcium homeostasis [76,99] (reviewed
in [88–90]). Finally, BNIP3 (Bcl-2/adenovirus E1B 19-kDa interacting
protein 3) is part of a BH3-only subfamily with poor conservation of
the BH3 domain. Localization of BNIP3 to the ER membrane facilitated
release of calcium and subsequently increased uptake of calcium into
mitochondria [97]. Thus, the balance between different components
of the BCL-2 family of proteins at the ER membrane may constitute a
“ﬁne tuning rheostat” for the regulation of calcium metabolism.
TMBIM family members such as TMBIM6/BI-1 and its orthologue
GAAP/TMBIM4 expression also alter ER calcium homeostasis possibly
downstream of the BCL-2 family where they reduce ER calcium
content [100–105].
At the biochemical and mechanistic level, several groups have
shown that BCL-2 and BCL-XL form a protein complexwith the inositol
triphosphate receptor (IP3R) [106–111], possibly modulating the
opening of a channel (Fig. 3). The IP3R, together with the ryanodine
receptor (RyR), are the main channels that control ER calcium release
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occurs at the ER membrane, negatively regulating its anti-apoptotic
activity [88], in addition to its ability to control the ER calcium content
[92,112]. Puriﬁcation of the native protein complexes containing BCL-
2 at the ER membrane identiﬁed the phosphatase PP2A [113] as an
interacting partner that dephosphorylates the sites targeted by JNK.
This regulation by PP2A may be also relevant to control ER calcium
homeostasis.
An inactivation and destabilization of the ER Ca2+ importer,
sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) is
caused by its direct interaction with BCL-2 [114–116], resulting in
reduced ER-calcium content. Thus, in summary, these data suggest
that depending on the cellular context and the stimuli, different BCL-2
containing protein complexes may exist at the ER membrane to
control calcium signaling. Hence, the balance between pro- and anti-
apoptotic BCL-2 related proteins at the ER determine the ER steady
state calcium content and the rate of calcium release after stimulation.
Calcium uptake by the mitochondria has a direct impact on the
susceptibility of a cell to undergo apoptosis, inﬂuencing the drop in
mitochondrial membrane potential, and the release of cytochrome c
and caspase activation (Fig. 4). Interestingly, in an elegant study,
Scorrano and co-workers described that the control of ER calcium by
BAX and BAK has a speciﬁc effect on calcium mediated-apoptosis (i.e.
arachidonic acid, ceramide or H2O2 treatment) and not ER stress [91].
On the other hand, reconstitution of BAX/BAK DKO cells with a
mitochondrial-targeted BAX recovered the susceptibility of these cells
to ER stress-induced apoptosis, without affecting the calcium
phenotype. Interestingly, cytosolic calcium increases could triggerFig. 4. Regulation of autophagy by the BCL-2 family members. (a) At the ER membrane BCL-2
Beclin-1 is negatively regulated through an interaction with BCL-2/BCL-XL at the ERmembran
get activated, where JNKmay phosphorylate BCL-2/BCL-XL, promoting autophagosome forma
autophagy through the transcriptional upregulation of ATG12, ATG5 and LC3. (e) The Beclin-
complex and LC3-II conversion to form autophagosomes. Lysosome fusion to the autophagos
(f) In addition, BNIP3 and ceramide signaling regulates autophagy.cytochrome c release independent of BAX and BAK through the
opening of the mitochondrial permeability transition pore (PTP), a
non-speciﬁc pore in the inner mitochondrial membrane (see reviews
in [117,118]). Opening of the PTP leads to dissipation of the
mitochondrial transmembrane potential (ΔΨm) and an inﬂux of
solutes. This causes expansion of the matrix, resulting in sufﬁcient
swelling to rupture the outer mitochondrial membrane and causing
cytochrome c release. Although the molecular identity of PTP remains
uncertain, different components are proposed; the best validated is
Cyclophilin D, a target of cyclosporin A. Thus, the control of calcium
metabolism by the BCL-2 family probably reﬂects a new function in
cell physiology beyond the direct control of apoptosis, but it indirectly
modulates mitochrondrial-mediated apoptosis through activation of
the PTP.
5. Role of the BCL-2 protein family in autophagy
Autophagy refers to the global process by which intracellular
components are recycled through lysosome degradation (reviewed in
[119]). Autophagy acts as a critical survival response under starvation
conditions in which the degradation of intracellular proteins and
organelles provides a source of amino acids during poor nutritional
conditions. Intracellular components can be delivered to lysosomes
for degradation by three different mechanisms known as macro-
autophagy, microautophagy and chaperone-mediated autophagy
[119,120]. The best-studied form of autophagy is macroautophagy,
hereafter referred to as autophagy. The hallmark of autophagy is the
formation of double-membrane-bounded autophagosomes [121].and BCL-XL are associated with the IP3R modulating BECLIN-dependent autophagy. (b)
e, and BH3-only proteins antagonize this interaction. (c) Upon ER stress, IRE1α and JNK
tion by releasing active Beclin-1/PI3K complex. (d) Activation of PERKmay also activate
1/PI3K complex initiates membrane nucleation by regulating downstream ATG12–ATG5
ome forms the active autophagolysosome where proteins and organelles are degraded.
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where intracellular components are degraded (Fig. 4). Autophagy is a
highly regulated process with complex steps that are controlled by a
family of autophagic related genes (termed atg genes) [119,122]. The
generation of atg deﬁcient mice unveiled the function of autophagy in
diverse processes, including development, cell differentiation, tissue
remodeling, immunity, host-to-pathogen response and cell death/
survival under stress conditions [119]. Beclin-1 (also known as Atg6)
is the ﬁrst identiﬁed mammalian autophagy gene product [123].
Beclin-1 is a haplo-insufﬁcient tumor suppressor that was originally
isolated as a BCL-2-interacting protein [124–126]. BCL-2 negatively
regulates Beclin-1 through a direct binding (Fig. 4) [127]. Surprisingly,
this regulatory activity of BCL-2 on autophagy is speciﬁcally attributed
to its expression at the ER membrane [127], suggesting that signaling
events originating from the ER are crucial for autophagy. It is
important to note that there is only a unidirectional regulation
between BCL-2 and Belclin-1, since Beclin-1 binding to BCL-2 does not
modify BCL-2 mediated apoptosis [128].
BCL-2/Beclin-1 complex formation also is regulated by BH3-only
proteins, suggesting an extensive crosstalk between apoptosis and the
autophagy regulatory components [129,130]. Most importantly, a
functional BH3-like domain was identiﬁed in Beclin-1 and its
mutation disrupted the interaction of Beclin-1 with BCL-XL [129].
Expression of BAD decreased the interaction between Beclin-1 and
BCL-XL at the ER membrane, and experiments performed in C. elegans
deﬁcient in EGL-1, a BH3 containing protein, corroborated this model
in vivo. Similarly, the pharmacological BH3 mimetic ABT-737
competitively inhibited the interaction between Beclin-1 and BCL-2/
BCL-XL, stimulating autophagy [129,130]. In addition, the BH3-only
protein BNIP3 has been shown to regulate autophagy under different
settings, possibly related to ceramide signaling [131–136]. It remains
to be determined if BNIP3 affects the stability of the BCL-2/Beclin-1
complex. Finally, another report indicates that phosphorylation of
BCL-2 by JNK is essential for the control of autophagy by Beclin-1
[137] (Fig. 4), a post-translational modiﬁcation that affects the
binding of BH3-only proteins to BCL-2 [92].
A connection between ER calcium homeostasis and autophagy
occurs also through the IP3R [138–140] (reviewed in [141]). Stimuli
that increase cytosolic calcium activate autophagy, which is blocked
by BCL-2 [140]. Blocking the IP3R modulates autophagy that arises
from speciﬁcally inhibiting BCL-2 or BCL-XL targeting to the ER
membrane. Unexpectedly, IP3R-dependent autophagy was attributed
to the activation of Beclin-1 and other autophagic related genes, and
this regulation was independent of calcium release, possibly due to a
role of IP3R as a scaffold protein rather than a calcium channel. Finally,
many laboratories have now shown that ER stress triggers autophagy,
an effect that is also regulated by UPR stress sensors [138,142–147].
Autophagymay serve as a mechanism to eliminate damaged ER under
stress conditions or to control the rate of ER expansion [145].
Unexpectedly, the activation of autophagy by ER stress requires
IRE1α and is not inhibited by BCL-2 overexpression, a strategy that
blocks autophagy mediated by IP3R, suggesting that there are at least
two independent pathways controlling autophagy from the ER [138].
However, it remains to be determined if the IRE1α/JNK signaling
branch regulates the BCL-2/Beclin-1 complex through phosphoryla-
tion. The direct phosphorylation of eIF2α by PERK is required for the
LC3 conversion, a fundamental process for autophagy induction [142].
The PERK branch of the UPR possibly regulates autophagy at the
transcriptional level [148,149].
6. Relationship between BCL-2 protein family and ER
morphogenesis
Some pro-apoptotic members also have a role in the regulation of
ER structure/function. Accordingly, co-expression of BAK with BCL-XL
or BAK mutant promote extensive swelling and vacuolization of ERcisternae [150]. Moreover, under similar conditions, the expression of
upstream BH3-only activators recapitulates ER swelling and vacuo-
lization just when RyR activity is inhibited. This effect is mediated by
BAK, but not by BAX [150]. In addition, BAX and BAKmay regulate the
ER biogenesis through the interaction with IRE1α and activation of
XBP-1 [43]. Moreover, experiments in non-apoptotic cells revealed a
role of BAX and BAK in mitochondrial morphogenesis [151].
Interestingly, it seems that these two pro-apoptotic multidomain
proteins are required for normal fusion of mitochondria into
elongated tubules [151].
The BH3-only protein BNIP1 is another pro-apoptotic protein
involved in the regulation of ER structure. In HeLa cells it has been
shown that BNIP1 is a component of a protein complex comprising
syntaxin18, an ER-located soluble N-ethylmaleimide-sensitive factor
(NSF) attachment protein receptor (SNARE) [152]. In addition, the
BH3-only domain plays an important role in the binding of α-SNAP,
an adaptor that serves as a link between the chaperone ATPase NSF
and SNAREs. These results, together with the known apoptotic
function of BNIP1, unmasked a possible crosstalk between apparently
independent cellular events such as apoptosis and ER membrane
fusion [152]. Interestingly, proteins linked to mitochondrial dynamics
(fusion and ﬁssion) also modulate ER morphogenesis and fragmen-
tation, related to the dynamics of ER–mitochondria contact sites [153–
155]. The physiological impact of the modulation of ER morphogen-
esis by the BCL-2 protein family remains to be determined.
7. Concluding remarks
The BCL-2 protein family is essential to mediate the crosstalk
between the ER and mitochondria to trigger apoptosis under
conditions of chronic or irreversible ER stress. The complexity of
mechanisms mediating this cell death process is diverse and may
depend on the speciﬁc type of ER injury and the cell type/tissue
affected. This review summarizes most evidence supporting an
evolutionary process whereby key regulators of cell death also
participate in vital cellular functions beyond apoptosis. Accordingly,
BCL-2-related proteins do not only operate as upstream regulators of
caspases, but they also actively perform speciﬁc cellular functions
related to ER physiology. In support of this idea, there is growing
evidence of non-apoptotic functions for the BCL-2 family beyond the
ER including cell cycle regulation [156,157], participation in DNA
damage responses (i.e. BID) [158,159], inﬂammation, (i.e. BCL-2)
[160] and glucose/energy metabolism (i.e. BAD) [161,162]. Here we
dissected the different BCL-2 family containing protein complexes at
the ER membrane and discussed their function in diverse cellular
processes. As a common denominator of their bi-functional activities,
the BCL-2 protein family may operate as specialized stress sentinels
that actively participate in crucial processes, allowing constant
homeostatic quality control to respond to irreversible cellular damage
activating adaptation to stress or apoptosis. Overall we propose a
model where complex signaling platforms are assembled at the level
of the ER membrane to determine the activation status of several
stress responses such as autophagy, calcium signaling, and the UPR in
terms of signaling intensity and kinetics of activation/inactivation. As
a stress rheostat, BCL-2-containing complexes would involve multiple
components that, beyond their anti- and pro-apoptotic effect on
mitochondrial integrity, act at the level of the ER membranes to
determine the capacity to adapt to ER injuries. In contrast, under
chronic ER stress, the expression of speciﬁc components (i.e. BIM,
PUMA, NOXA, and other factors) would induce BAX and/or BAK
activation at the mitochondria to trigger cytochrome c release and
apoptosis [36,77,82,163].
Mutations in certain genes are responsible for a variety of
neurological disorders related to the misfolding and accumulation of
abnormal protein aggregates in the brain. In many of these diseases
alteration of ER homeostasis contributes to neuronal dysfunction.
571D. Rodriguez et al. / Biochimica et Biophysica Acta 1813 (2011) 564–574These diseases include Parkinson's disease [164], Alzheimer's disease
[165], Prion diseases [166] Amyotrophic Lateral Sclerosis (ALS) [167],
Huntington's disease [168] and many others. Consequently, the ﬁrst
steps in the death pathways downstream of ER stress may represent
important therapeutic targets. In addition, BH3-only proteins, such as
BIM and PUMA, have been implicated in Alzheimer's disease [25],
Huntington's disease [169,170] and ALS [171,172], in addition to brain
ischemia [173–175] in vivo. Thus, pharmacological manipulation of
BCL-2 protein family activity may be beneﬁcial in the treatment of
these fatal diseases related to ER stress. A number of small molecules
and synthetic peptides are currently available with proven therapeu-
tic applications in disease mouse models, including BCL-2 inhibitors
[176,177], BAX channel inhibitors [87], BAX/BAK activator peptides
[178,179] and many others (see reviews in [66,180]). These drugs
may be used as pharmacological tools to manipulate the activity of
stress signaling pathways regulated by the BCL-2 protein family (i.e.
autophagy, calciummetabolism or the UPR) and alter their function in
pathological conditions.
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